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The therapeutic success of TNFa blockade in RA is unique
and has been largely considered to result from rapid and
efficient neutralization of joint inflammation based on
breakdown of the inflammatory cytokine network in the
affected joint, which results in an improvement of the signs
and symptoms of the disease (4). It has, however, always
been stunning, how fast the blockade of TNFa improves
the patient condition, in particular since diseases like RA
are highly chronic, building up a vast amount of inflamma-
tory tissue and leading to irreversible damage of the carti-
lage and the bone. Thus, rapid resolution of this highly
organized inflammatory tissue and/or tissue damage is very
unlikely to explain the fast effect of TNFa blockade. There
has always been a gap in understanding of how tumor
necrosis factor alpha (TNFa) blockade affects the disease
state of arthritis patients so rapidly, considering that dis-
eases like rheumatoid arthritis are very chronic conditions.
We thus hypothesized that blockade of TNFa acts through
the central nervous system (CNS) before directly affecting
joint inflammation. By use of functional magnetic reso-
nance imaging (fMRI), we demonstrate that within
24 hours after neutralization of TNFa nociceptive CNS
activity in the thalamus and somatosensoric cortex but also
the activation of the limbic system is blocked. Brain areas
showing blood oxygen level dependent (BOLD) signals, a
validated method to assess neuronal activity elicited by
pain, were significantly reduced as early as 24 hours after
initiation of TNFa blockade. In contrast, clinical and
laboratory markers of inflammation such as joint swelling
and acute phase reactants were not affected by TNFa
blockade at these early time points. Moreover, arthritic
mice overexpressing human TNFa showed an altered pain
behavior and a more intensive, widespread and prolonged
brain activity upon nociceptive stimuli as compared to
wild-type mice. Similar to humans, these changes as well as
the rewiring of CNS activity resulting in tight clustering in
the thalamus were rapidly reversed after neutralization of
TNFa. These results suggest that neutralization of TNFa
affects nociceptive brain activity in the context of arthritis,
long before it achieves anti-inflammatory effects in the
joints.
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